1. Effects of chemokine receptor 3 gene silencing by RNA interference on eosinophils
    Yuehui Liu et al, 2017, Experimental and Therapeutic Medicine CrossRef
  2. Potential Therapeutic Targets of Resveratrol, a Plant Polyphenol, and Its Role in the Therapy of Various Types of Cancer
    Saleh A. Almatroodi et al, 2022, Molecules CrossRef
  3. Different Biological Pathways Between Good and Poor Inhaled Corticosteroid Responses in Asthma
    Byung-Keun Kim et al, 2021, Frontiers in Medicine CrossRef
  4. Use of Natural Products in Asthma Treatment
    Lucas Amaral-Machado et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
  5. Cellular and Molecular Targets of Resveratrol on Lymphoma and Leukemia Cells
    Raffaele Frazzi et al, 2017, Molecules CrossRef
  6. Review Deciphering the Anticancer Efficacy of Resveratrol and their Associated Mechanisms in Human Carcinoma
    Mohd Arif et al, 2024, Endocrine, Metabolic & Immune Disorders - Drug Targets CrossRef
  7. A comprehensive review of the health perspectives of resveratrol
    Abdur Rauf et al, 2017, Food & Function CrossRef
  8. Endosulfan induces cell dysfunction through cycle arrest resulting from DNA damage and DNA damage response signaling pathways
    Jialiu Wei et al, 2017, Science of The Total Environment CrossRef
  9. Molecular Nutrition and Epigenetics
    Dragan Milenkovic et al, 2018, Reference Module in Food Science CrossRef
  10. The Role of Resveratrol in Cancer Management: From Monotherapy to Combination Regimens
    Eduarda Ribeiro et al, 2024, Targets CrossRef
  11. The DNA methylation of FOXO3 and TP53 as a blood biomarker of late-onset asthma
    Lin Yuan et al, 2020, Journal of Translational Medicine CrossRef
  12. Active ingredients from Chinese medicine plants as therapeutic strategies for asthma: Overview and challenges
    Wenqian Wang et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  13. An Updated Comprehensive Review of Plants and Herbal Compounds with Antiasthmatic Effect
    Mohammad Amin Rajizadeh et al, 2024, Evidence-Based Complementary and Alternative Medicine CrossRef